LFG
MED icon

Larson Financial Group’s Medifast MED Stock Holding History

Larson Financial Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$40 – 3414
2025
Q1 		$40 Hold
3
– – ﹤0.01% 3004
2024
Q4 		$53 Hold
3
– – ﹤0.01% 2695
2024
Q3 		$57 Hold
3
– – ﹤0.01% 2627
2024
Q2 		$65 Buy
+3
New +$80 ﹤0.01% 2326

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Larson Financial Group's MED Position: Q2 2025 in Review

Larson Financial Group sold out of Medifast (MED) in Q2 2025, closing a stake of 3 shares — an estimated $40 sold.

Larson Financial Group first reported a position in MED in Q2 2024 and held it in 4 quarters. The position peaked at $65 in Q2 2024. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Larson Financial Group reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Larson Financial Group sold 3 Medifast shares in Q2 2025, an estimated $40.
  • Larson Financial Group first reported a position in Medifast in Q2 2024 and held it in 4 quarters.
  • Larson Financial Group's Medifast position peaked at $65 in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.